Dear buyers! Unfortunately, we are currently unable to accept the application to Canada and are revoking the license. Keep an eye on the site to see if there are any updates from Canada.
Catalog
Client
Currency:
Contacts
Our location:
Ternopil city
Contacts
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Wishlist
0
Compare
0
Contacts

Nefopam-Zdorovye solution for injection 20 mg/2 ml ampoule 2 ml in blister No. 5

SKU: an-1054796
0
All about product
Description
Specification
Reviews 0
Questions0
new
Nefopam-Zdorovye solution for injection 20 mg/2 ml ampoule 2 ml in blister No. 5
In Stock
577.50 грн.
Active ingredient:Nefopam hydrochloride
Adults:Can
ATC code:N AGENTS ACTING ON THE NERVOUS SYSTEM; N02 ANALGETICS; N02B OTHER ANALGETICS AND ANTIPYRETICS; N02B G Other analgesics and antipyretics; N02B G06 Nefopam
Country of manufacture:Ukraine
Diabetics:Can
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Nefopam-Zdorovye solution for injection 20 mg/2 ml ampoule 2 ml in blister No. 5
577.50 грн.
Description

Nefopam-Health injection solution is used for the following indications:

postoperative analgesia as part of multimodal analgesia (nefopam also exhibits a positive property of preventing postoperative tremor); symptomatic treatment of acute pain conditions (injuries, pain after surgical operations, analgesia of renal and hepatic colic).

Composition

The active substance is nefopam hydrochloride (one ampoule (2 ml) of the drug contains 20 mg of nefopam hydrochloride).

Excipients: sodium hydrogen phosphate, sodium dihydrogen phosphate anhydrous, water for injections.

Contraindication

hypersensitivity to nefopam or other components of the drug; children's age up to 15 years, due to the lack of clinical studies; seizures or their presence in history; risk of urinary retention associated with urethroprostatic disorders; risk of acute glaucomatous attack; simultaneous use of MAO inhibitors.

Method of application

Therapy should correspond to the intensity of the pain syndrome and the patient's response.

Intramuscular injection

The drug should be administered intramuscularly deep. A dose of 20 mg is recommended for one injection. If necessary, the injection should be repeated every 6 hours. The maximum daily dose is 120 mg.

Intravenous administration

The drug should be administered as a continuous infusion over at least 15 minutes, the patient should be in a supine position to avoid some adverse reactions, such as nausea, dizziness, sweating. The dose per injection is 20 mg. If necessary, repeat the injection every 4 hours.

The maximum daily dose is 120 mg.

Introduction method

The drug can be administered in a standard infusion solution (0.9% sodium chloride solution or 5% glucose solution). The optimal dilution ratio is one ampoule of the drug in 50 ml of infusion solution.

The course of treatment is no more than 8-10 days.

Application features

Pregnant women

For safety reasons, the drug should not be used during pregnancy.

The drug passes into breast milk to such an extent that exposure to breastfed newborns/infants is likely. Should not be used during breastfeeding.

Children

Do not use in children under 15 years of age.

Drivers

The possible risk of drowsiness during treatment should be taken into account, which may affect the ability to drive or operate other mechanisms.

Overdose

Symptoms of anticholinergic origin: tachycardia, coma, convulsions, hallucinations.

Treatment: symptomatic treatment with cardiological and respiratory monitoring in a hospital setting.

Side effects

From the nervous system: very often (≥ 1/10) - drowsiness; often (≥ 1/100, <1/10) - dizziness.

Cardiac disorders: often (≥ 1/100, <1/10) - tachycardia, palpitations.

Gastrointestinal tract: very often (≥ 1/10) - nausea, vomiting; often (≥ 1/100, <1/10) - dry mouth.

Renal and urinary disorders: common (≥ 1/100, <1/10) - urinary retention.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.

Shelf life - 2 years.

Specifications
Characteristics
Active ingredient
Nefopam hydrochloride
Adults
Can
ATC code
N AGENTS ACTING ON THE NERVOUS SYSTEM; N02 ANALGETICS; N02B OTHER ANALGETICS AND ANTIPYRETICS; N02B G Other analgesics and antipyretics; N02B G06 Nefopam
Country of manufacture
Ukraine
Diabetics
Can
Dosage
10 mg/ml
Drivers
With caution, drowsiness is possible.
For allergies
With caution
For children
From the age of 15
Form
Ampoules
Method of application
Injections
Nursing
It is impossible.
Pregnant
It is impossible.
Primary packaging
ampoule
Producer
Health FC LLC
Quantity per package
5 ampoules
Trade name
Nefopam
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.